報價延遲最少15分鐘:2025/01/11 17:17 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.8207 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.46/-0.63
|
|
企業價值
79.37M
|
| 資產負債 |
|
每股賬面淨值
1.07
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
391.70K
|
|
每股收益
0.00
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/11 17:17 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with apotential in-class mechanism of action. |